Evaluation of Fructosamine 3-kinase and Glyoxalase 1 activity in normal and breast cancer tissues

Authors

Tooba Yousefi, 1. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IRAN 2. Department of Clinical Biochemistry, Babol University of Medical Sciences, Babol, IRAN 3. Student Research Committee, Babol University of Medical Sciences, Babol, IRANFollow
Abdol Rahim Gholizadeh Pasha, Department of Surgery, School of Medicine, Babol University of Medical Sciences, Babol, IRAN
Ghodsieh Kamrani, Department of Pathology, School of Medicine, Babol University of Medical Sciences, Babol, IRAN
Ailin ebrahimzadeh, Department of Clinical Biochemistry, Babol University of Medical Sciences, Babol, IRAN
Ali Zahedian, Department of Surgery, School of Medicine, Babol University of Medical Sciences, Babol, IRAN
Karimollah hajian-Tilaki, Department of Epidemiology and Biostatistics, School of Medicine, Babol University of Medical Sciences, Babol,IRAN
mohammad Aghajani, Shahid Beheshti hospital, Babol University of Medical Sciences, Babol, IRAN
Durdi Qujeq, 1. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IRAN 2. Department of Clinical Biochemistry, Babol University of Medical Sciences, Babol, IRANFollow

Abstract

Background: Breast cancer is a typical malignancy and the most common in the female and it is the primary reason behind cancer-related deaths of women around the world. The pathological role of the non-enzymatic change of proteins by reducing sugars become frequently shows in different kinds of cancer. Cancer cells generally rely upon aerobic glycolysis as the main source of energy. Impaired glucose metabolism is somewhat responsible for the aggregation of advanced glycation end products (AGEs). Methylglyoxal (MG), a glycolysis byproduct either contributes to the accumulation of AGEs. Enzymatic defense upon AGEs products exists in all mammalian cells. Aims: The present work intends to look into Glyoxalase1 (GLO1) and fructosamine-3- kinase (FN3K) activity in human breast carcinoma.

Methods: Thirty-three consecutive patients were entered into the study. Samples of breast tumoral tissue and normal matches were drawn from patients after surgery. FN3K and GLO1 enzymatic activity were analyzed using a radiometric and spectrophotometric assay.

Results: The average level of FN3K enzyme was fundamentally lower in cancerous tissues parallel with adjacent noncancerous tissues. We also observed a consistent increase of GLO1 activity in the tumor parallel with pair-matched normal tissue.

Conclusion: The current findings build up a key-role of enzymatic defense to detoxify cytotoxic AGEs and methylglyoxal levels in tumor cells. These discoveries may give another system to the treatment of breast cancer.

Recommended Citation

Yousefi, Tooba; Gholizadeh Pasha, Abdol Rahim; Kamrani, Ghodsieh; ebrahimzadeh, Ailin; Zahedian, Ali; hajian-Tilaki, Karimollah; Aghajani, mohammad; and Qujeq, Durdi (2021) "Evaluation of Fructosamine 3-kinase and Glyoxalase 1 activity in normal and breast cancer tissues," BioMedicine: Vol. 11 : Iss. 3 , Article 3.
DOI: 10.37796/2211-8039.1130

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.